Cancer Science & Therapy

Global Summit on Oncology & Cancer

May 25-27, 2017 Osaka, Japan

Scientific Tracks Abstracts

• Identification and validation of HLA-A24 XBP1, CD138, and CS1 peptides and induction of antigensspecific CD8+ T cell immunity using a multipeptide cocktail: Preclinical basis for vaccine therapy in HLA-A24 patients with

  Jooeun Bae, Derin Keskin, Jun Zhou, Guanglan Zhang, Dharminder Chauhan, Teru Hideshima, Noopur Raje, Paul Richardson, Nikhil Munshi and Kenneth C Anderson

  PDF HTML

• Mesenchymal stem cells in inflammatory microenvironment promotes cancer cell migration and epithelialmesenchymal transition through osteopontin

  Tzu-Ching Chang and Chia-Cherng Yu

  PDF HTML

• Down regulation of trans-membrane and coiled-coil domain 1 in urinary bladder urothelial carcinoma: A characterization of tumor suppressor function impairs AKT signaling pathway

  Yow-Ling Shiue, Wen-Ren Wu, Chien-Feng Li and Cheng-Tang Pan

  PDF HTML

• Validation of a novel therapeutic target for targeted radionuclide-antibody therapy of malignant pleural effusion

  Jaecheong Lim

  PDF HTML

• Brazilian natural compound FLAV5: A promising anticancer drug

  Giovanna Barbarini Longato, Yollanda Edwirges Moreira Franco, Patricia de Oliveira Carvalho, Denise Gonçalves Priolli and Claudia Quintino da Rocha

  PDF HTML

• High expression of pyruvate dehydrogenase kinase in cholangiocarcinoma patients

  Surangkana Sanmai, Tanakorn Proungvitaya, Temduang Limpaiboon, Sittiruk Roytrakul, Daraporn Chua-on, Doungdean Tummanatsakun and Siriporn Proungvitaya

  PDF HTML

• Serum apurinic/apyrimidinic endodeoxyribonuclease 1 in cholangiocarcinoma patients

  Doungdean Tummanatsakun, Tanakorn Proungvitaya, Temduang Limpaiboon, Sittiruk Roytrakul and Siriporn Proungvitaya

  PDF HTML

• High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma

  Daraporn Chua-on, Tanakorn Proungvitaya, Anchalee Techasen, Temduang Limpaiboon, Sittiruk Roytrakul and Siriporn Proungvitaya

  PDF HTML

• Sphk2 inhibitor ABC294640 enhances cell death in NSCLC cells via downregulation and proteasomedependent degradation of c-FLIPL

  Hasanifard Leili, Samadi Nasser, Rashtchizadeh Nadereh and Dastmalchi Siavoush

  PDF HTML

• The potential of circulating tumor cells (CTCs) in personalized management of breast cancer: A systematic review

  Fatemeh Khatami, Hamid Reza Aghayan, Maryam Sanaei, Ramin Heshmat, Seyed Mohammad Tavangar and BagherLarijani

  PDF HTML